Takafumi Mie

Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis

Takuji Okusaka, Masahiro Yoshida, Masayuki Kitano et al. · International Journal of Clinical Oncology · 2023 · 171 citations · Full text

Medicine, Oncology, Surgery +17

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer

Masashi Sawada, Akiyoshi Kasuga, Takafumi Mie et al. · BMC Cancer · 2020 · 74 citations · Full text

Medicine, Oncology, Pharmacology +14

The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy

Tsuyoshi Takeda, Takashi Sasaki, Chisaki Suzumori et al. · International Journal of Clinical Oncology · 2021 · 52 citations

Medicine, Geriatric Medicine, Oncology +14

Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study

Yuta Ushida, Yosuke Inoue, Atsushi Oba et al. · Annals of Surgical Oncology · 2022 · 49 citations

Medicine, Oncology, Surgery +12

Early-onset pancreatic cancer: Clinical characteristics and survival outcomes

Tsuyoshi Takeda, Takashi Sasaki, Yosuke Inoue et al. · Pancreatology · 2022 · 28 citations

Medicine, Oncology, Surgery +11